Inhibitors of topoisomerase are widely used in clinical settings. Topoisomerase I inhibitors include camptothecin and its derivatives, which trap the enzyme in a covalent complex with DNA, preventing the re-ligation step. Topoisomerase II inhibitors include etoposide and doxorubicin, which stabilize the DNA double-strand breaks created by the enzyme, leading to cell death.